Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation

Form: 8-K
Filed: Sep 29, 2021, 4:37 pm ET
Period: Sep 24, 2021
Importance: Major
Accession: 0001213900-21-050592
Document: 8-K
Exhibit 10.2: Amended and restated registration rights agreement, dated September 24, 2021…
Exhibit 10.3: Jasper Therapeutics, Inc. 2021 equity incentive plan
Exhibit 10.4: Jasper Therapeutics, Inc. 2021 equity incentive plan form of stock option grant
Exhibit 10.5: Jasper Therapeutics, Inc. 2021 equity incentive plan form of RSU award grant…
Exhibit 10.6: Jasper Therapeutics, Inc., 2021 employee stock purchase plan
Exhibit 10.7: Employment agreement, dated as of September 24, 2021, by and between jasper…
Exhibit 10.8: Employment agreement, dated as of September 24, 2021, by and between jasper…
Exhibit 10.9: Employment agreement, dated as of September 24, 2021, by and between jasper…
Exhibit 10.14: Amendment to sponsor support agreement, dated as of September 24, 2021, by and…
Exhibit 99.1: Press release, dated September 24, 2021

Signs a material agreement (1.01)
Completes an acquisition or sale of assets (2.01)
Sells unregistered shares (3.02)
Changes its auditor (4.01)
Reports a change in control (5.01)
Reports an executive or board change (5.02)
Changes its shell company status (5.06)
Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.